Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Economic impact of multiple sclerosis in Italy: focus on rehabilitation costs.
Cost-Effectiveness Analyses in Multiple Sclerosis: A Review of Modelling Approaches.
Impairment of JCV-specific T-cell response by corticotherapy: Effect on PML-IRIS management?
The Neurite Outgrowth Inhibitory Nogo-A-Δ20 Region Is an Intrinsically Disordered Segment Harbouring Three Stretches with Helical Propensity.
Rapidly progressive amyotrophic lateral sclerosis initially masquerading as a demyelinating neuropathy.
Cell-specific effects in different immune subsets associated with SOCS1 genotypes in multiple sclerosis.
Protein kinase Cβ as a therapeutic target stabilizing blood-brain barrier disruption in experimental autoimmune encephalomyelitis.
Isoprostanes in clinically isolated syndrome and early multiple sclerosis as biomarkers of tissue damage and predictors of clinical course.
Multiple sclerosis genetics.
Neuromuscular electrical stimulation cycling exercise for persons with advanced multiple sclerosis.
Changing paradigm to target microglia in neurodegenerative diseases: from anti-inflammatory strategy to active immunomodulation.
Oxidative stress and neurodegenerative disease.
Modulating effects of WT1 on interferon-β-vitamin D association in MS.
Neuropsychological features in childhood and juvenile multiple sclerosis: Five-year follow-up.
GABA transport and neuroinflammation are coupled in multiple sclerosis: Regulation of the GABA transporter-2 by ganaxolone.
New insights into an autoimmune mechanism, pharmacological treatment and relationship between multiple sclerosis and inflammatory bowel disease.
Role of toll-like receptor 2 in ischemic demyelination and oligodendrocyte death.
TRPV1 Gates Tissue Access and Sustains Pathogenicity in Autoimmune Encephalitis.
Computer-Assisted Cognitive Rehabilitation of Attention Deficits for Multiple Sclerosis: A Randomized Trial With fMRI Correlates.
Microglia as a critical player in both developmental and late-life CNS pathologies.
Patient perspectives on physician conflict of interest in industry-sponsored clinical trials for multiple sclerosis therapeutics.
RP-CARS: label-free optical readout of the myelin intrinsic healthiness.
Sexual function in women with multiple sclerosis.
Biogen Reports Top-Line Results from Phase 3 Study Evaluating Natalizumab in Secondary Progressive MS
Sexual dysfunction in women with multiple sclerosis: Dimensions and contributory factors.
Pages
« first
‹ previous
…
348
349
350
351
352
353
354
355
356
…
next ›
last »